These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35981800)

  • 1. The Association of Clustered Ventricular Arrhythmia and Cycle Length With Scar Burden in Cardiomyopathy.
    Vakil RM; Marine JE; Kolandaivelu A; Dickfeld T; Weiss RG; Tomaselli GF; Chrispin J; Wu KC
    JACC Clin Electrophysiol; 2022 Aug; 8(8):957-966. PubMed ID: 35981800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
    Middour TG; Rosenthal TM; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Bober RM; Morin DP
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1137-1146. PubMed ID: 32064730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
    Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
    Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.
    Kotake Y; Nalliah CJ; Campbell T; Bennett RG; Turnbull S; Kumar S
    J Interv Card Electrophysiol; 2023 Jan; 66(1):5-14. PubMed ID: 34787768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity.
    Gould J; Porter B; Claridge S; Chen Z; Sieniewicz BJ; Sidhu BS; Niederer S; Bishop MJ; Murgatroyd F; Ganeshan B; Carr-White G; Razavi R; Chiribiri A; Rinaldi CA
    Heart Rhythm; 2019 Aug; 16(8):1242-1250. PubMed ID: 30849532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD.
    Rijnierse MT; van der Lingen ACJ; de Haan S; Becker MAJ; Harms HJ; Huisman MC; Lammertsma AA; van de Ven PM; van Rossum AC; Knaapen P; Allaart CP
    JACC Cardiovasc Imaging; 2020 Aug; 13(8):1755-1766. PubMed ID: 32305468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure).
    Flett A; Cebula A; Nicholas Z; Adam R; Ewings S; Prasad S; Cleland JG; Eminton Z; Curzen N
    Am Heart J; 2023 Dec; 266():149-158. PubMed ID: 37777041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the phenotype of mixed cardiomyopathy in patients with implantable cardioverter-defibrillators.
    Raja DC; Samarawickrema I; Menon SK; Singh R; Mehta A; Tuan LQ; Pandurangi U; Jain S; Callans DJ; Marchlinski FE; Abhayaratna WP; Sanders P; Pathak RK
    J Interv Card Electrophysiol; 2024 Jan; 67(1):129-137. PubMed ID: 37273034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scar Characterization to Predict Life-Threatening Arrhythmic Events and Sudden Cardiac Death in Patients With Cardiac Resynchronization Therapy: The GAUDI-CRT Study.
    Acosta J; Fernández-Armenta J; Borràs R; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Andreu D; Soto-Iglesias D; Evertz R; Matiello M; Alonso C; Villuendas R; de Caralt TM; Perea RJ; Ortiz JT; Bosch X; Serra L; Planes X; Greiser A; Ekinci O; Lasalvia L; Mont L; Berruezo A
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):561-572. PubMed ID: 28780194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain echocardiography improves prediction of arrhythmic events in ischemic and non-ischemic dilated cardiomyopathy.
    Melichova D; Nguyen TM; Salte IM; Klaeboe LG; Sjøli B; Karlsen S; Dahlslett T; Leren IS; Edvardsen T; Brunvand H; Haugaa KH
    Int J Cardiol; 2021 Nov; 342():56-62. PubMed ID: 34324947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators.
    Elsokkari I; Parkash R; Tang A; Wells G; Doucette S; Yetisir E; Gardner M; Healey JS; Thibault B; Sterns L; Birnie D; Nery P; Sivakumaran S; Essebag V; Dorian P; Sapp J
    JACC Clin Electrophysiol; 2020 Mar; 6(3):327-337. PubMed ID: 32192684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar.
    Gutman SJ; Costello BT; Papapostolou S; Voskoboinik A; Iles L; Ja J; Hare JL; Ellims A; Kistler PM; Marwick TH; Taylor AJ
    Eur Heart J; 2019 Feb; 40(6):542-550. PubMed ID: 30107489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
    Rijnierse MT; de Haan S; Harms HJ; Robbers LF; Wu L; Danad I; Beek AM; Heymans MW; van Rossum AC; Lammertsma AA; Allaart CP; Knaapen P
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):20-30. PubMed ID: 24343851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy.
    Narins CR; Aktas MK; Chen AY; McNitt S; Ling FS; Younis A; Zareba W; Daubert JP; Huang DT; Rosero S; Kutyifa V; Goldenberg I
    JACC Clin Electrophysiol; 2022 Jan; 8(1):1-11. PubMed ID: 34454875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.